These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26248421)

  • 21. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
    Kiesecker C; Alter M; Kathöfer S; Zitron E; Scholz EP; Thomas D; Kreuzer J; Katus HA; Bauer A; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):212-20. PubMed ID: 16736158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
    Ridley JM; Milnes JT; Hancox JC; Witchel HJ
    J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
    Melgari D; Brack KE; Zhang C; Zhang Y; El Harchi A; Mitcheson JS; Dempsey CE; Ng GA; Hancox JC
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25911606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local anesthetic interaction with human ether-a-go-go-related gene (HERG) channels: role of aromatic amino acids Y652 and F656.
    Siebrands CC; Schmitt N; Friederich P
    Anesthesiology; 2005 Jul; 103(1):102-12. PubMed ID: 15983462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells.
    Du X; Lu D; Daharsh ED; Yao A; Dewoody R; Yao JA
    J Pharmacol Toxicol Methods; 2006; 54(2):164-72. PubMed ID: 16782359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Determinants for the High-Affinity Blockade of Human Ether-à-go-go-Related Gene K + Channel by Tolterodine.
    Wang N; Yang Y; Wen J; Fan XR; Li J; Xiong B; Zhang J; Zeng B; Shen JW; Chen GL
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):679-689. PubMed ID: 35881423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural requirements of human ether-a-go-go-related gene channels for block by bupivacaine.
    Siebrands CC; Friederich P
    Anesthesiology; 2007 Mar; 106(3):523-31. PubMed ID: 17325511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656.
    Scholz EP; Zitron E; Kiesecker C; Thomas D; Kathöfer S; Kreuzer J; Bauer A; Katus HA; Remppis A; Karle CA; Greten J
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):666-75. PubMed ID: 16926094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The calmodulin inhibitor N-(6-aminohexyl)-5-chloro-1-naphthalene sulphonamide directly blocks human ether à-go-go-related gene potassium channels stably expressed in human embryonic kidney 293 cells.
    Zhang XH; Jin MW; Sun HY; Zhang S; Li GR
    Br J Pharmacol; 2010 Oct; 161(4):872-84. PubMed ID: 20860665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
    Guo J; Gang H; Zhang S
    J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procaine, a state-dependent blocker, inhibits HERG channels by helix residue Y652 and F656 in the S6 transmembrane domain.
    Wang N; Ma JH; Zhang PH
    J Pharmacol Sci; 2013 Sep; 123(1):25-35. PubMed ID: 24005047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
    Limberis JT; Su Z; Cox BF; Gintant GA; Martin RL
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1059-65. PubMed ID: 17042915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis.
    Dong ZX; Zhao X; Gu DF; Shi YQ; Zhang J; Hu XX; Hu MQ; Yang BF; Li BX
    Cell Physiol Biochem; 2012; 29(3-4):431-42. PubMed ID: 22508050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.
    Ridley JM; Milnes JT; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2004 Dec; 325(3):883-91. PubMed ID: 15541373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome.
    Takemasa H; Nagatomo T; Abe H; Kawakami K; Igarashi T; Tsurugi T; Kabashima N; Tamura M; Okazaki M; Delisle BP; January CT; Otsuji Y
    Br J Pharmacol; 2008 Feb; 153(3):439-47. PubMed ID: 17965736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone.
    Zitron E; Kiesecker C; Scholz E; Lück S; Bloehs R; Kathöfer S; Thomas D; Kiehn J; Kreye VA; Katus HA; Schoels W; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):146-56. PubMed ID: 15322737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
    Scholz EP; Zitron E; Kiesecker C; Lueck S; Kathöfer S; Thomas D; Weretka S; Peth S; Kreye VA; Schoels W; Katus HA; Kiehn J; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):404-14. PubMed ID: 14557918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline.
    Hiramatsu M; Wu LM; Hirano Y; Kawano S; Furukawa T; Hiraoka M
    Heart Vessels; 2004 May; 19(3):137-43. PubMed ID: 15168062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.